Amicus Therap Us Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AMICUS THERAP US, and when can generic versions of AMICUS THERAP US drugs launch?
AMICUS THERAP US has two approved drugs.
There are sixty-nine US patents protecting AMICUS THERAP US drugs.
There are three hundred and thirty-three patent family members on AMICUS THERAP US drugs in forty-three countries and twenty-four supplementary protection certificates in seventeen countries.
Summary for Amicus Therap Us
| International Patents: | 333 |
| US Patents: | 69 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Amicus Therap Us
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amicus Therap Us | GALAFOLD | migalastat hydrochloride | CAPSULE;ORAL | 208623-001 | Aug 10, 2018 | RX | Yes | Yes | 11,278,540 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Amicus Therap Us | GALAFOLD | migalastat hydrochloride | CAPSULE;ORAL | 208623-001 | Aug 10, 2018 | RX | Yes | Yes | 9,095,584 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Amicus Therap Us | GALAFOLD | migalastat hydrochloride | CAPSULE;ORAL | 208623-001 | Aug 10, 2018 | RX | Yes | Yes | 11,357,763 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Amicus Therap Us | GALAFOLD | migalastat hydrochloride | CAPSULE;ORAL | 208623-001 | Aug 10, 2018 | RX | Yes | Yes | 11,234,972 | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Amicus Therap Us Drugs
Supplementary Protection Certificates for Amicus Therap Us Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2787345 | C20160037 00206 | Estonia | ⤷ Sign Up | PRODUCT NAME: MIGALASTAAT;REG NO/DATE: EU/1/15/1082 31.05.2016 |
| 3201320 | 2024C/513 | Belgium | ⤷ Sign Up | PRODUCT NAME: CIPAGLUCOSIDASE ALFA; AUTHORISATION NUMBER AND DATE: EU/1/22/1714 20230324 |
| 2787345 | PA2016033 | Lithuania | ⤷ Sign Up | PRODUCT NAME: MIGALASTATAS ARBA JO DRUSKA, ISKAITANT IR HIDROCHLORIDO DRUSKA; REGISTRATION NO/DATE: EU/1/15/1082 20160526 |
| 2787345 | PA2016033,C2787345 | Lithuania | ⤷ Sign Up | PRODUCT NAME: MIGALASTATAS ARBA JO DRUSKA, ISKAITANT IR HIDROCHLORIDO DRUSKA; REGISTRATION NO/DATE: EU/1/15/1082 20160526 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
